ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,148Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 387

$785K Total Retail Price of All Prescriptions

Rank: 53 out of 387

504 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,647 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 712 686 1 5
OMEPRAZOLE 575 530 2 4
HYDROCODONE-ACETAMINOPHEN 482 380 S3 3 1
ZOLPIDEM TARTRATE 420 341 4 16
LEVOTHYROXINE SODIUM 397 389 5 2
AMLODIPINE BESYLATE 356 346 6 6
LISINOPRIL 321 309 7 3
METFORMIN HCL 311 281 8 8
LOSARTAN POTASSIUM 284 258 9 24
FUROSEMIDE 279 259 10 7
SERTRALINE HCL 233 184 11 23
METOPROLOL SUCCINATE 227 214 12 18
ATORVASTATIN CALCIUM 189 185 13 13
TAMSULOSIN HCL 189 181 13 32
CITALOPRAM HBR 184 161 15 19
METOPROLOL TARTRATE 173 154 16 11
WARFARIN SODIUM 172 168 17 17
DIOVAN 171 146 18 33
MELOXICAM 168 156 19 22
FLUTICASONE PROPIONATE 165 150 20 29
TRAMADOL HCL 163 155 21 14
POTASSIUM CHLORIDE 163 157 21 9
CRESTOR 162 152 23 34
GLIMEPIRIDE 142 138 24 50
GABAPENTIN 142 110 24 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 109 26 30
PRAVASTATIN SODIUM 135 133 27 15
CARVEDILOL 129 109 28 21
DIOVAN HCT 122 122 29 74
DONEPEZIL HCL 122 122 29 27
CYMBALTA 115 82 31 44
SYNTHROID 108 96 32 68
SPIRIVA 107 61 33 61
PREDNISONE 100 80 34 43
FINASTERIDE 100 97 34 95
CYCLOBENZAPRINE HCL 95 78 R 36 42
HYDROCHLOROTHIAZIDE 94 81 37 12
KLOR-CON M20 93 88 38 76
AZITHROMYCIN 82 69 39 49
ADVAIR DISKUS 80 51 40 41
AMLODIPINE BESYLATE-BENAZEPRIL 78 76 41 54
CLOPIDOGREL 77 77 42 25
NAMENDA 76 76 43 35
ALLOPURINOL 75 75 44 28
VERAPAMIL ER 72 72 45 87
ACTOS 69 69 46 99
DIGOXIN 68 68 47 40
ATENOLOL 68 68 47 20
LYRICA 66 48 49 66
PANTOPRAZOLE SODIUM 66 65 49 48
EXFORGE 66 66 49 157
ESTRADIOL 62 55 R 52 105
LOSARTAN-HYDROCHLOROTHIAZIDE 61 61 53 65
VENLAFAXINE HCL ER 60 48 54 97
NEXIUM 59 44 55 26
LEVOFLOXACIN 59 48 55 84
VENTOLIN HFA 56 32 57 142
DICLOFENAC SODIUM 55 51 58 115
PLAVIX 54 54 59 39
ESCITALOPRAM OXALATE 53 43 60 73
JANUVIA 53 48 60 60
AMOX TR-POTASSIUM CLAVULANATE 52 45 62 131
CARBIDOPA-LEVODOPA 51 44 63 104
POLYETHYLENE GLYCOL 3350 50 30 64 57
JANUMET 50 50 64 193
CIPROFLOXACIN HCL 50 44 64 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.